Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income

S&P Global Market Intelligence, citing sell-side forecasts, projects that most publicly traded US health insurers will post quarter-over-quarter declines in revenue and net income for Q2 2025. Among the eight largest managed care insurers, nearly all are expected to see sequential drops, with only UnitedHealth Group, Alignment Healthcare (revenue), and The Cigna Group (net income) as exceptions. Crucially, while all eight are forecast for year-over-year revenue growth, they are also uniformly projected to report lower year-over-year net income, signaling widespread margin compression.

Analysis

Sell-side analyst forecasts for Q2 2025 indicate a challenging period for the US health insurance sector, with a majority of publicly traded companies expected to experience quarter-over-quarter declines in both revenue and net income. A critical insight from the S&P Global Market Intelligence analysis is the divergence between top-line and bottom-line year-over-year performance. While all eight of the largest managed care insurers are projected to report higher revenue compared to Q2 2024, all eight are also simultaneously forecast to post lower net income over the same period, signaling significant, sector-wide margin compression. There are minor exceptions to the sequential weakness, with UnitedHealth Group and Alignment Healthcare projected to avoid the QoQ revenue dip, and The Cigna Group expected to be the only one to avoid a QoQ net income decline. Nonetheless, the unanimous forecast for a year-over-year drop in profitability underscores broad operational or cost pressures facing the industry.

Key Decisions for Investors

• Investors should adopt a cautious stance towards the managed care sector, as the universal forecast for year-over-year net income declines points to significant industry-wide margin compression despite top-line growth.
• Consider differentiating within the sector by focusing on relative strength, as companies like UnitedHealth and Alignment Healthcare are projected to show more resilient sequential revenue performance.
• Closely monitor upcoming Q2 earnings releases for management commentary on cost trends and margin outlook, as this will be more critical than the widely expected year-over-year revenue growth.